Press "Enter" to skip to content

ImmunoGen Axing Nearly 75% of Workforce, Shrinking Pipeline and Facilities – Genetic Engineering & Biotechnology News

admin 0

ImmunoGen Axing Nearly 75% of Workforce, Shrinking Pipeline and Facilities  Genetic Engineering & Biotechnology News

ImmunoGen is eliminating nearly three-quarters of its workforce—220 jobs—and doubling down on developing its lead antibody-drug conjugate (ADC), the …

“ovarian cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *